Director, PRESIDENT and CEO · LeonaBio, Inc. · LeonaBio, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
750.0K
Price
—
Executed
Apr 9, 2026
Disclosed
Apr 13, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Apr 9 executedApr 13, 2026 disclosed
LONA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Litton Mark James filed this Form 4 reporting a grant or award of LONA on Apr 9, 2026. It became public on Apr 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, PRESIDENT and CEO
Litton Mark Jamescik:0001604834
Issuer
LeonaBio, Inc.cik:0001620463
Revision history · 0
No field has changed since this record was first ingested.
